PEPG: PepGen Corp Total Debt to Capital
The prospects for the biotechnology sector rely on the creation of effective means for regenerating muscle functions in hereditary pathologies. This price chart for PepGen Inc. (PEPG) demonstrates a debt-to-equity ratio of 0.12. Development is funded through partnerships with industry behemoths, as the company lacks the internal capital for mergers. Unique RNA therapies and patent protection for drug delivery methods ensure stable demand.
%20-%20Debt%20to%20Capital&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_PEPG_-_PepGen-Inc._-_Debt-to-Capital "Total Debt to Equity Ratio: PepGen (PEPG) for 04/28/2023 - 10/29/2026 | 👁️GURU.Markets👁️")
Metric breakdowns and analytics for PepGen (PEPG)
- price and consensus price forecast:
- market capitalization information:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
- earnings and market ratios statistics:
Summary company analytics:PepGen Inc., PEPG
Developing a unique EDO platform for muscular dystrophy therapy, PepGen Inc. requires significant R&D investments, which is reflected in the current total debt-to-equity ratio of 0.12. This ratio compares total liabilities to equity, measuring financial leverage and the biotech firm's reliance on borrowed capital to assess business resilience against default risks.
Competitors of PepGen Inc.
Debt to Equity Biogen|Debt to Equity Ratio NBIX (Neurocrine)|Total Debt to Capital RGC|AXSM - Debt to Capital|ACADIA Pharmaceuticals - Total Debt to Equity Ratio|Total Debt to Capital xenon-pharma.com XENE|VKTX - Debt to Equity|All Debt to Shareholders' Equity Ratio SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Debt to Equity|Debt to Capital Denali Corp (DNLI)|Debt to Equity Harmony Biosciences|biohavenpharma.com - Aggregate Debt to Equity|Total Debt to Capital AMLX|TRVI - Debt to Capital|Debt to Equity Praxis Medicines PRAX|AVXL (Anavex Life Sciences Corp) - Aggregate Debt to Equity|CeriBell, Inc. - Total Debt to Capital|Debt to Capital Ratio Prothena Corporation PLC (PRTA)|ALEC: Total Debt to Capital|Debt to Capital Annexon Biosciences (ANNX)|Debt to Equity Omeros Corp|Debt to Equity Ratio NGNE (Neurogene Therapeutics)|Total Debt to Equity Ratio ACIU (AC Immune)|VYGR (voyagertherapeutics.com) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital NMRA (Neumora Therapeutics, Inc.)|Total Debt to Capital Coefficient Scilex Holding (SCLX)|TVGN - Debt to Equity|ACOG (Alpha Cognition) - Debt to Equity Ratio|CGTX: Total Debt to Capital|Total Debt to Equity Ratio inhibikase.com|Total Debt to Equity Ratio SAVA|Assertio Therapeutics (ASRT) - Total Debt to Capital Coefficient|Debt to Equity Coya Therapeutics, Inc. (COYA)|VTGN: Aggregate Debt to Equity|Total Debt to Capital OVID (Ovid Therapeutics)|acumenpharm.com (ABOS) - Debt to Capital|CRVO - Debt to Equity|Aggregate Debt to Equity ATHE|CLNN: Total Debt to Capital|Debt to Capital Ratio Jupiter Neurosciences, Inc. JUNS|Debt to Equity Relmada Therapeutics|Debt to Equity Ratio ANVS (annovisbio.com)|Total Debt to Capital GRCE|AIFF - Debt to Capital|Klotho Neurosciences - Total Debt to Equity Ratio|Total Debt to Capital NeuroSense Therapeutics Ltd NRSN|RVPH - Debt to Equity|All Debt to Shareholders' Equity Ratio MTVA (MetaVia Inc)|NeurAxis (NRXS) - Debt to Equity|Debt to Capital Helius Medical Technologies (HSDT)|Debt to Equity Passage Bio Inc.|Neuphoria - Aggregate Debt to Equity|Total Debt to Capital NERV|ATHA - Debt to Capital|Debt to Equity Addex Therapeutics Ltd ADXN|ALZN (Alzamend Neuro Inc.) - Aggregate Debt to Equity|Cyclerion - Total Debt to Capital|Debt to Capital Ratio Protagenic Therapeutics (PTIX)|KTTA: Total Debt to Capital|Debt to Capital Cortigent (CRGT)|Debt to Equity Avenue Therapeutics, Inc.|Debt to Equity Ratio BCLI (Brainstorm Cell Therapeutics Inc.)|Total Debt to Equity Ratio CARA (Cara Therapeutics, Inc)|CHRO (Chromocell) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital ELYM (Eliem Therapeutics Inc.)|Total Debt to Capital Coefficient Intra-Cellular Therapies Inc. (ITCI)|LBPH - Debt to Equity|MRNS (Marinus Pharmaceuticals Inc) - Debt to Equity Ratio|NKGN: Total Debt to Capital|Total Debt to Equity Ratio NeuroBo Pharma|Total Debt to Equity Ratio SAGE|synaptogen.com (SNPX) - Total Debt to Capital Coefficient|Debt to Equity Trevena (TRVN)|VIGL: Aggregate Debt to Equity|Total Debt to Capital WENA (Anew Medical)|Cerevel Corp (CERE) - Debt to Capital